Clinical Laboratories
New Developments in Leukemia Apr 20, 2021 9 am PT / Noon ET Host: Derek Lyle, MD; Medical Director, NeoGenomics Speaker: Daniel A. Arber, MD; Chair of Pathology and Donald West and Mary Elizabeth King Professor of Pathology, The...
How Motic Uses Digital Pathology to Combat Cervical Cancer Cervical cancer is considered a leading cause of cancer-related deaths among women worldwide. Let that sink in — a cancer that’s largely preventable by the HPV vaccine and, at...
Join Visiopharm at USCAP 2021
- Artificial Intelligence
- Business
- Clinical Laboratories
- Cloud Computing
- Conferences
- Data Management
- Device Manufacturers
- Digital Pathology Conferences
- Digital Pathology News
- Education
- File format
- Image Analysis
- Laboratory Management & Operations
- Marketing
- New Digital Imaging Technologies
- Pathology News
- Training
- Vendor products
- Webinars
Get the insights and inspiration you need at USCAP 2021 with Visiopharm, a world leader in AI-driven digital precision pathology software. On the agenda Exhibitor seminar: Join Visiopharm’s Chief Clinical and Regulatory Officer,...
Proscia and Ibex Medical Analytics Partner to Improve Prostate Canc...
- Artificial Intelligence
- Business
- Clinical Laboratories
- Data Management
- Device Manufacturers
- Digital Pathology News
- File format
- Image Analysis
- Informatics
- International
- Laboratory Informatics
- Laboratory Management & Operations
- Marketing
- Medical Research
- New Digital Imaging Technologies
- Pathology News
- Press Release
- Tissue banking
- Vendor products
Collaboration to enhance quality and efficiency in routine diagnosis PHILADELPHIA & TEL AVIV, Israel--(BUSINESS WIRE)--Proscia®, a leading provider of digital and computational pathology solutions, and Ibex Medical Analytics, the...
TissueScope iQ Receives Health Canada and CE-IVD Over the past month, Huron's 400 slide TissueScope iQ achieved two important regulatory approvals, Health Canada and CE-IVD for Europe. With these certifications, Huron is accelerating its...
Roche receives FDA approval for VENTANA ALK (D5F3) CDx Assay to identify lung cancer patients eligible for targeted treatment with LORBRENA (lorlatinib) About 235,000 people in the US will be diagnosed with lung cancer...
